Edition:
United States

People: Celldex Therapeutics Inc (CLDX.A)

CLDX.A on American Stock Exchange

2.35USD
10 Jul 2019
Change (% chg)

-- (--)
Prev Close
$2.35
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
348
52-wk High
$9.00
52-wk Low
$2.41

Keler, Tibor 

Dr. Tibor Keler, Ph.D., serves as Executive Vice President and Chief Scientific Officer of Celldex Therapeutics Inc. since July 30, 2014. Since, May 2003, Dr. Keler has held a number of positions with Celldex, including a founder, Senior Vice President and Chief Scientific Officer of Celldex, from March 2008 to July 2014, and Vice President, Research and Discovery and Chief Scientific Officer, from May 2003 to March 2008. In addition, he was Senior Director of Preclinical Development and Principal Scientist at Medarex from September 1993 to March 2004. While at Medarex, he was responsible for the development of Celldex's technology and products, as well as for the preclinical development and testing of numerous Medarex products now in clinical trials. Dr. Keler received his Ph.D. in Microbiology from the University of Pennsylvania.

Basic Compensation

Total Annual Compensation, USD 574,453
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 174,260
Fiscal Year Total, USD 748,713

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Larry Ellberger

127,469

Anthony Marucci

1,385,350

Sam Martin

622,246

Tibor Keler

748,713

Sarah Cavanaugh

--

Elizabeth Crowley

585,708
As Of  30 Dec 2018